RLMD
Relmada Therapeutics Inc
3.60$
-1.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 100.0% | 99.9% | 99.9% | 100.0% | 100.0% | 99.9% | 99.9% | 99.9% | 100.0% | 100.0% | 100.0% | |
| 6.1% | 4.2% | 1.6% | 2.9% | 2.7% | 8.4% | 4.2% | 6.4% | 9.3% | 3.7% | 4.2% | 5.2% | |
| 97.4% | 98.7% | 99.1% | 99.2% | 97.1% | 98.0% | 97.8% | 97.6% | 93.3% | 98.9% | 99.4% | 99.4% | |
| – | – | – | – | – | – | – | – | – | – | – | 0.0% | |
| 7.7% | 12.5% | 14.6% | 13.4% | 14.5% | 22.5% | 18.9% | 24.5% | 36.4% | 8.0% | 7.1% | 5.7% | |
| 7.7% | 12.5% | 14.6% | 13.4% | 14.5% | 22.5% | 18.9% | 24.3% | 34.9% | 6.8% | 5.5% | 3.4% | |
| 2.6% | 3.6% | 6.1% | 5.9% | 4.2% | 9.0% | 4.6% | 6.4% | 9.8% | 1.7% | 2.4% | 1.1% | |
| 92.3% | 87.5% | 85.4% | 86.6% | 85.5% | 77.5% | 81.1% | 75.5% | 63.6% | 92.0% | 92.9% | 94.3% | |
| -490.8% | -575.0% | -690.4% | -845.4% | -1,116.6% | -1,398.8% | -2,378.8% | -3,164.9% | -4,560.3% | -742.8% | -304.8% | -333.3% | |
| 27.6% | 30.9% | 35.7% | 42.5% | 54.1% | 65.9% | 109.9% | 157.2% | 223.1% | 72.6% | 36.8% | 51.3% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.